Zusammenfassung
Bei den primär malignen Leberkarzinomen unterscheidet man zwischen dem hepatozellulären Karzinom (HCC), das in 80–90 % aller malignen Primärtumoren der Leber auftritt, von dem selteneren Cholangiokarzinom (CC), das ungefähr 10 % der malignen Lebertumoren ausmacht. Seltene epitheliale Tumoren (wie das biliäre Zystadenokarzinom), mesenchymale Tumoren (wie das Hämangiosarkom oder Fibrosarkom) sowie kombinierte Tumoren (Mischtumoren von hepatozellulärem und Cholangiokarzinom) oder Hepatoblastome werden aufgrund der Seltenheit von <1 % nicht weiter aufgeführt.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Kojiro M, Wanless IR, Alves V, Badve S, Balabaud C, Bedossa P, Bhathal P et al (2009) Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia. Hepatology 49(2):658–664
EASL-EORTC (2012) clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56(4):908–943
Ascha MS, Hanouneh IA, Lopez R, Tamimi TA, Feldstein AF, Zein NN (2010) The incidence and risk factors of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. Hepatology 51(6):1972–1978
Baffy G, Brunt EM, Caldwell SH (2012) Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. J Hepatol 56(6):1384–1391
Bosetti C, Levi F, Boffetta P, Lucchini F, Negri E, La Vecchia C (2008) Trends in mortality from hepatocellular carcinoma in Europe, 1980-2004. Hepatology 48(1):137–145
Chang MH (2009) Cancer prevention by vaccination against hepatitis B. Recent Results Cancer Res 181:85–94
Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN et al (2006) Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 295(1):65–73
Chuma M, Sakamoto M, Yamazaki K, Ohta T, Ohki M, AsakaMet al (2003) Expression profiling in multistage hepatocarcinogenesis: identification of HSP70 as a molecular marker of early hepatocellular carcinoma. Hepatology 37(1):198–207
Di Tommaso L, Franchi G, Park YN, Fiamengo B, Destro A, Morenghi E et al (2007) Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis. Hepatology 45(3):725–734
Forner A, Vilana R, Ayuso C, Bianchi L, Sole M, Ayuso JR et al (2008) Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology 47(1):97–104
Greten TF, Manns MP (2008) Das hepatozelluläre Karzinom. Dtsch Med Wochenschr 133:1907–1910
Greten TF, Papendorf F, Bleck JS, Kirchhoff T, Wohlberedt T, Kubicka S et al (2005) Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients. Br J Cancer 92(10):1862–1868
Hassan MM, Hwang LY, Hatten CJ, Swaim M, Li D, Abbruzzese JL et al (2002) Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 36(5):1206–1213
Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF et al (2008) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359(4):378–390
Lok AS, Seeff LB, Morgan TR, di Bisceglie AM, Sterling RK, Curto TM et al (2009) Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. Gastroenterology 136(1):138–148
Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP (2006) The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 45(4):529–538
Roskams T, Kojiro M (2010) Pathology of early hepatocellular carcinoma: conventional and molecular diagnosis. Semin Liver Dis 30(1):17–25
Tanaka H, Imai Y, Hiramatsu N, Ito Y, Imanaka K, Oshita M et al (2008) Declining incidence of hepatocellular carcinoma in Osaka, Japan, from 1990 to 2003. Ann Intern Med 148(11):820–826
Zhang BH, Yang BH, Tang ZY (2004) Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 130(7):417–422
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Schmidt, S., Vogel, A. (2016). Maligne primäre Lebertumoren. In: Manns, M., Schneidewind, S. (eds) Praxis der Hepatologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-41620-0_30
Download citation
DOI: https://doi.org/10.1007/978-3-642-41620-0_30
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-41619-4
Online ISBN: 978-3-642-41620-0
eBook Packages: Medicine (German Language)